Evidence map›Paper›PMID 40568222›Full record

ArticleACS catalysis2025

Nile Red-Based Covalent Organic Framework as a Photocatalyst for C-H Bond Functionalization.

Marta Gordo-Lozano, Diego G Matesanz, Marcos Martínez-Fernández, Pedro Almendros, Emiliano Martínez-Periñán, José L Segura, Sara Cembellín

Abstract read
In one paragraph

Article in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta Gordo-LozanoMacromolecular and Heterocyclic Organic Materials Group, Organic Chemistry Department, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid 28040, Spain.ORCID https://orcid.org/0000-0002-2764-6157
Diego G MatesanzGreen Catalysis Laboratory, Organic Chemistry Department, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid 28040, Spain.
Marcos Martínez-FernándezMacromolecular and Heterocyclic Organic Materials Group, Organic Chemistry Department, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid 28040, Spain.ORCID https://orcid.org/0000-0001-7447-491X
Pedro AlmendrosInstituto de Química Orgánica General, IQOG-CSIC, Consejo Superior de Investigaciones Científicas, Madrid 28006, Spain.ORCID https://orcid.org/0000-0001-6564-2758
Emiliano Martínez-PeriñánSensors and Biosensors group, Departamento de Química Analítica y Análisis Instrumental, Facultad de Ciencias, and Institute for Advanced Research in Chemical Sciences (IAdChem), Universidad Autónoma de Madrid, Campus de Cantoblanco, Madrid 28049, Spain.ORCID https://orcid.org/0000-0003-3122-3381
José L SeguraMacromolecular and Heterocyclic Organic Materials Group, Organic Chemistry Department, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid 28040, Spain.ORCID https://orcid.org/0000-0002-3360-1019
Sara CembellínGreen Catalysis Laboratory, Organic Chemistry Department, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid 28040, Spain.ORCID https://orcid.org/0000-0001-9884-9042

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The search for efficient photocatalysts based on covalent organic frameworks (COFs) is an area of increasing interest. However, the development of these heterogeneous photocatalysts is hindered by the symmetry restrictions of the linkers used to construct these materials. Herein, we report the straightforward synthesis of an imine-based 2D-COF,

Indexed as

C−H functionalizationCOFheterogeneous catalysisNile Redphotocatalysis

Identifiers

PMID40568222
PMCPMC12186703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.